Strafford will be offering a webinar entitled "Biotech Patents and Section 101 Rejections: Meeting Patent Eligibility Requirements — Leveraging Recent Decisions and USPTO Guidance to Overcome Rejections" on February 12, 2019 from 1:00 to 2:30 pm (EST).  Amanda K. Murphy, Steven P. O'Connor, Sanya Sukduang, and Sara A. Leiman of Finnegan Henderson Farabow Garrett & Dunner will guide patent counsel for overcoming § 101 rejections for biotech patents, review recent case law and USPTO guidance on § 101 patent eligibility, and offer strategies to address § 101 rejections.  The webinar will review the following issues:

• The impact of the Mayo, Myriad, and Ariosa decisions on recent USPTO and Federal Circuit decisions addressing § 101 rejections for biotech and other technological patents
• Problems with the USPTO guidance documents and examiner training
• Potential strategies to overcome § 101 rejection
• Robust patent specification and claim drafting tips

The registration fee for the webcast is $347.  Those interested in registering for the webinar, can do so here.